Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationMulticenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
- Where
- Changsha
- People
- 200
- Run by
- Yue Gou
See details and how to joinNCT06849362 - No phaseTaking peopleCD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
- Where
- Taiyuan
- Age
- 15 years to 80 years
- People
- 15
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT06850285 - Phase 1/2Taking peopleSafety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
- Where
- Dongguan, Guangzhou, Shanghai
- Age
- 1 year to 50 years
- People
- 10
- Run by
- Sun Yat-Sen University Cancer Center
See details and how to joinNCT06836505 - No phaseTaking peopleDREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC
- Where
- Shanghai
- People
- 508
- Run by
- Baohui Han
See details and how to joinNCT06846762 - No phaseTaking peopleIntrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma
- Where
- Shanghai
- People
- 18
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT04903678 - Phase 1Taking peoplePhase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
- Where
- Guangzhou
- Age
- 1 day to 18 years
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT06631391 - Phase 3Taking peopleA Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
- Where
- Guangzhou
- Age
- 0 years to 18 years
- People
- 300
- Run by
- Yizhuo Zhang
See details and how to joinNCT06836492 - No phaseNot yet taking people in ChinaGene Therapy for Neurofibromatosis Type 2 (NF2) with ST002
- Where
- Beijing
- Age
- 16 years and over
- People
- 9
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06834438 - Phase 1/2Taking peopleCAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
- Where
- Beijing
- Age
- 14 years to 75 years
- People
- 20
- Run by
- Affiliated Hospital to Academy of Military Medical Sciences
See details and how to joinNCT06834529 - Phase 2Taking peopleChemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia
- Where
- Shanghai
- Age
- 16 years to 65 years
- People
- 100
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05870995 - Phase 2Taking peopleTreatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia
- Where
- Guangzhou, Huai'an, Nanchang, Shanghai
- Age
- 16 years to 70 years
- People
- 30
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05881265 - Phase 3Taking peopleRandomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
- Where
- Fuzhou, Kunming, Nanjin, Nanning, Shanghai, Suzhou, Xiamen
- Age
- 16 years to 55 years
- People
- 222
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05991908 - Phase 2Taking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
- Where
- Zhengzhou
- Age
- 1 year to 17 years
- People
- 276
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06559345 - Phase 2Taking peopleA Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
- Where
- Zhengzhou
- Age
- 1 year to 17 years
- People
- 170
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06564493 - No phaseTaking peopleClinical Study of Carbon Ion Radiotherapy for High-grade Glioma
- Where
- Wuwei
- Age
- 14 years to 80 years
- People
- 23
- Run by
- Gansu Wuwei Tumor Hospital
See details and how to joinNCT06831773 - Phase 3Taking peopleComparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
- Where
- Hangzhou
- Age
- 14 years to 75 years
- People
- 81
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06361329 - No phaseTaking peopleA Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
- Where
- Guangzhou
- People
- 500
- Run by
- Sun Yat-sen University
See details and how to joinNCT06829147 - No phaseTaking peopleThe Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study
- Where
- Xi'an
- People
- 40
- Run by
- Xijing Hospital
See details and how to joinNCT06830512 - Phase 1/2Taking peopleTranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
- Where
- Hangzhou
- Age
- 10 years to 80 years
- People
- 150
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06023212 - No phaseEnrolling by invitationCorrelation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions
- Where
- Hangzhou
- People
- 280
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06816212 - Phase 2Taking peopleEvaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
- Where
- Jinan
- Age
- 2 years to 18 years
- People
- 38
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06816771 - Phase 1Taking peopleChimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
- Where
- Nanjing
- Age
- 1 year to 12 years
- People
- 12
- Run by
- Nanjing Children's Hospital
See details and how to joinNCT06751134 - No phaseTaking peoplePredicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
- Where
- Chengdu
- People
- 10,000
- Run by
- West China Hospital
See details and how to joinNCT06810349 - Phase 3Taking peopleA Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
- Where
- Xi'an
- Age
- 16 years to 80 years
- People
- 400
- Run by
- Second Affiliated Hospital of Xi'an Jiaotong University
See details and how to joinNCT06791005 - No phaseTaking peopleEvaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
- Where
- Beijing
- Age
- 3 years to 80 years
- People
- 50
- Run by
- Peking University Third Hospital
See details and how to joinNCT06791226